Effects of d-α-tocopherol supplements on lipid metabolism in a high-fat diet-fed animal model
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
High-fat diet up-regulates either insulin resistance or triglycerides, which is assumed to be related to the expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ. The beneficial effects of vitamin E on insulin resistance are well known; however, it is not clear if vitamin E with a high-fat diet alters the expression of PPAR-α and PPAR-γ. We investigated the effects of d-α-tocopherol supplementation on insulin sensitivity,blood lipid profiles, lipid peroxidation, and the expression of PPAR-α and PPAR-γ in a high-fat (HF) diet-fed male C57BL/6J model of insulin resistance. The animals were given a regular diet (CON; 10% fat), a HF diet containing 45% fat, or a HF diet plus d-α-tocopherol (HF-E) for a period of 20 weeks. The results showed that the HF diet induced insulin resistance and altered the lipid profile, specifically the triglyceride (TG)and total cholesterol (TC) levels (P < 0.05). In this animal model, supplementation with d-α-tocopherol improved insulin resistance as well as the serum levels of TG and very-low-density lipoprotein-cholesterol (VLDL-C) (P < 0.05). Moreover, the treatment decreased the levels of malondialdehyde (MDA) in the serum and liver while increasing hepatic PPAR-α expression and decreasing PPAR-γ expression. In conclusion, the oral administration of d-α-tocopherol with a high-fat diet had positive effects on insulin resistance, lipid profiles, and oxidative stress through the expression of PPAR-αand PPAR-γ in a high-fat diet-fed male mice.
Abstract
High-fat diet up-regulates either insulin resistance or triglycerides, which is assumed to be related to the expression of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ. The beneficial effects of vitamin E on insulin resistance are well known; however, it is not clear if vitamin E with a high-fat diet alters the expression of PPAR-α and PPAR-γ. We investigated the effects of d-α-tocopherol supplementation on insulin sensitivity,blood lipid profiles, lipid peroxidation, and the expression of PPAR-α and PPAR-γ in a high-fat (HF) diet-fed male C57BL/6J model of insulin resistance. The animals were given a regular diet (CON; 10% fat), a HF diet containing 45% fat, or a HF diet plus d-α-tocopherol (HF-E) for a period of 20 weeks. The results showed that the HF diet induced insulin resistance and altered the lipid profile, specifically the triglyceride (TG)and total cholesterol (TC) levels (P < 0.05). In this animal model, supplementation with d-α-tocopherol improved insulin resistance as well as the serum levels of TG and very-low-density lipoprotein-cholesterol (VLDL-C) (P < 0.05). Moreover, the treatment decreased the levels of malondialdehyde (MDA) in the serum and liver while increasing hepatic PPAR-α expression and decreasing PPAR-γ expression. In conclusion, the oral administration of d-α-tocopherol with a high-fat diet had positive effects on insulin resistance, lipid profiles, and oxidative stress through the expression of PPAR-αand PPAR-γ in a high-fat diet-fed male mice.
참고문헌 (30)
- Lovejoy JC, "Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance", Metabolism, 50, pp.86~92 (2001)
- Mayer-Davis EJ, "Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS)", Am J Clin Nutr, 65, pp.79~87 (1997)
- Lovejoy JC, "Effect of a controlled high-fat versus low-fat diet on insulin sensitivity and leptin levels in African-American and Caucasian women", Metabolism, 47, pp.1520~1524 (1998)
- Hardwick JP, "PPAR", RXR regulation of fatty acid metabolism and fatty acid omega-hydroxylase (CYP4) isozymes: implications for prevention of lipotoxicity in fatty liver disease, 2009, pp.2009, 952734~
- Carmena R, "Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance", Am Heart J, 150, pp.859~870 (2005)
- Sugden MC, "Potential role of peroxisome proliferatoractivated receptor-alpha in the modulation of glucose-stimulated insulin secretion", Diabetes, 53(Suppl 1), pp.S71~S81 (2004)
- Robinson E, "Significance of peroxisome proliferatoractivated receptors in the cardiovascular system in health and disease", Pharmacol Ther, 122, pp.246~263 (2009)
- Manning PJ, "Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects", Diabetes Care, 27, pp.2166~2171 (2004)
- Raso GM, "Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat", Eur J Pharmacol, 604, pp.125~131 (2009)
- González R, "Cytoprotective properties of alpha-tocopherol are related to gene regulation in cultured D-galactosamine-treated human hepatocytes", Free Radic Biol Med, 43, pp.1439~1452 (2007)
- Folch J, "A simple method for the isolation and purification of total lipides from animal tissues", J Biol Chem, 226, pp.497~509 (1957)
- Winzell MS, "The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes", Diabetes, 53(Suppl 3), pp.S215~S219 (2004)
- Facchini FS, "Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols", Am J Clin Nutr, 72, pp.776~779 (2000)
- Muis MJ, "alpha-Tocopherol levels in plasma in new-onset, insulin-dependent diabetes mellitus", Eur J Intern Med, 15, pp.371~374 (2004)
- Paolisso G, "Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients", Am J Clin Nutr, 57, pp.650~656 (1993)
- Costacou T, "Plasma and dietary vitamin E in relation to insulin secretion and sensitivity", Diabetes Obes Metab, 10, pp.223~228 (2008)
- Codoñer-Franch P, "A matter of fat: insulin resistance and oxidative stress", Pediatr Diabetes, 13, pp.392~399 (2012)
- Rudich A, "Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes", Diabetologia, 42, pp.949~957 (1999)
- Maddux BA, "Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of α-lipoic acid", Diabetes, 50, pp.404~410 (2001)
- Vinayagamoorthi R, "Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance", J Endocrinol, 197, pp.287~296 (2008)
- Altavilla D, "IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury", Cardiovasc Res, 47, pp.515~528 (2000)
- Terra X, "Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet", J Nutr Biochem, 20, pp.210~218 (2009)
- Azzi A, "Regulation of gene expression by alpha-tocopherol", Biol Chem, 385, pp.585~591 (2004)
- Braissant O, "Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat", Endocrinology, 137, pp.354~366 (1996)
- Yu S, "Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression", J Biol Chem, 278, pp.498~505 (2003)
- Yakaryilmaz F, "Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study", Intern Med J, 37, pp.229~235 (2007)
- Serisier S, "Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs", Br J Nutr, 99, pp.1208~1216 (2008)
- Tsuboyama-Kasaoka N, "Upregulation of liver uncoupling protein-2 mRNA by either fish oil feeding or fibrate administration in mice", Biochem Biophys Res Commun, 257, pp.879~885 (1999)
- Srivastava RA, "Fenofibrate ameliorates diabetic and dyslipidemic profiles in KKAy mice partly via down-regulation of 11beta-HSD1, PEPCK and DGAT2. Comparison of PPARalpha, PPAR gamma, and liver × receptor agonists", Eur J Pharmacol, 607, pp.258~263 (2009)
- Matsusue K, "Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes", J Clin Invest, 111, pp.737~747 (2003)